BioNxt Solutions Inc. (OTCMKTS:BNXTF) Sees Large Drop in Short Interest

BioNxt Solutions Inc. (OTCMKTS:BNXTF) saw a significant decrease in short interest in the month of October. As of October 15th, there was short interest totaling 1,000 shares, a decrease of 83.3% from the September 30th total of 6,000 shares. Based on an average trading volume of 11,286 shares, the days-to-cover ratio is presently 0.1 days. Approximately 0.0% of the company’s stock are sold short.

BioNxt Solutions Price Performance

Shares of BioNxt Solutions stock opened at $0.21 on Thursday. The stock has a market cap of $28.58 million, a price-to-earnings ratio of -4.20 and a beta of 0.75. The firm’s 50-day moving average is $0.24 and its two-hundred day moving average is $0.31. BioNxt Solutions has a 1 year low of $0.10 and a 1 year high of $0.79.

BioNxt Solutions (OTCMKTS:BNXTF) last posted its quarterly earnings results on Friday, August 28th. The company reported ($0.01) EPS for the quarter.

BioNxt Solutions Company Profile

BioNxt Solutions Inc is a Canadian life sciences company focused on developing pharmaceutical and diagnostic products using alternative drug-delivery technologies. Its platform work includes orally dissolvable films, transdermal delivery systems and related formulations intended to improve the convenience, dosing and absorption of established medicines.

The company’s development programs have included therapies for neurological and other medical conditions, as well as diagnostic applications.